S. Lu

Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.

J. Houck, J. Klucik, K. Berlin, 1999, Journal of medicinal chemistry.

Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.

R. Baruchello, M. Roberti, N. D’alessandro, 2001, Journal of medicinal chemistry.

Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.

J. Klucik, K. Berlin, D. Benbrook, 1999, Journal of medicinal chemistry.

Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.

K. Berlin, L. W. Spruce, D. Hill, 1997, Journal of medicinal chemistry.

Synthesis, Characterization and Crystal Structure of (Z)-1-[2-(Tri-o-tolylstannyl)vinyl]-1-cyclopentanol and Its o-Tolylhalostannyl Derivatives

Y. Mu, Y. Zhang, W. Gao, 2003 .

Nonanolides of natural origin: structure, synthesis, and biological activity.

K. Krohn, P. Sun, L. Li, 2012, Current medicinal chemistry.

A new polymorph of NH 4 V 3 O 7 : Synthesis, structure, magnetic and electrochemical properties

G. Zakharova, R. Klingeler, Quanyao Zhu, 2016 .